IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjogren′s syndrome
Du, Yan1; Su, Yin1; He, Jing1; Yang, Yue1; Shi, Yamei2; Cui, Yong3; Luo, Cainan2; Wu, Xinyu1; Liu, Xu1; Hu, Fanlei1; Ma, Xiaoxu1; Zheng, Li1; Zhang, Jing1; Zuo, Xianbo3; Sheng, Yujun3; Wu, Lijun2; Zhang, Xuejun3; Guo, Jianping1; Li, Zhanguo1
刊名ANNALS OF THE RHEUMATIC DISEASES
2015-11-01
DOI10.1136/annrheumdis-2013-204441
74期:11页:2070-2075
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Rheumatology
资助者National Key Basic Research Program of China (973 program) ; Program of International Science &amp ; Technology Cooperation of MOST ; Major International Joint Research Project of NSFC ; National Natural Science Foundation of China ; Education Ministry&prime ; s New Century Outstanding Talents Supporting Plan ; Beijing Natural Science Foundation ; National Key Basic Research Program of China (973 program) ; Program of International Science &amp ; Technology Cooperation of MOST ; Major International Joint Research Project of NSFC ; National Natural Science Foundation of China ; Education Ministry&prime ; s New Century Outstanding Talents Supporting Plan ; Beijing Natural Science Foundation
研究领域[WOS]Rheumatology
关键词[WOS]CLASS-I MOLECULES ; RHEUMATOID-ARTHRITIS ; MULTIPLE-SCLEROSIS ; ASSOCIATION ; CLASSIFICATION ; DEFICIENCY ; SELECTION ; DELETION ; CRITERIA ; PROTEIN
英文摘要

Background Recently, our research group identified the non-deleted (functional) leucocyte immunoglobulin-like receptor A3 (LILRA3) as a new genetic risk for rheumatoid arthritis.

Objectives To further investigate whether the functional LILRA3 is a new susceptibility factor for other autoimmune diseases for example, systemic lupus erythematosus (SLE) and primary Sjogren′s syndrome (pSS).

Methods The LILRA3 deletion polymorphism and its tagging single nucleotide polymorphism rs103294 were genotyped for 1099 patients with SLE, 403 patients with pSS and 2169 healthy controls. Association analyses were performed in whole dataset or clinical/serological subsets. The impact of LILRA3 on SLE activity and LILRA3 expression was evaluated.

Results The functional LILRA3 conferred high susceptibility to both SLE (p=3.51x10(-7), OR=2.03) and pSS (p=1.40x10(-3), OR=2.32). It was associated with almost all the clinical/serological features in SLE, especially with leucopenia (p=4.09x10(-7), OR=2.19) and thrombocytopenia (p=1.68x10(-5), OR=1.70). In pSS, functional LILRA3 was specifically associated with leucopenia (p=4.39x10(-4), OR=3.25), anti-Ro/SSA-positive subphenotypes (p=4.54x10(-3), OR=2.34) and anti-La/SSB-positive subphenotypes (p=0.012, OR=2.49). Functional LILRA3 conferred higher disease activity in patients with SLE (p=0.044) and higher LILRA3 expression in both SLE (p=5.57x10(-8)) and pSS (p=1.49x10(-7)) than in controls.

Conclusions Functional LILRA3 is a new susceptibility factor for SLE and pSS. It highly predisposes to certain phenotypes such as leucopenia and thrombocytopenia in SLE, and may confer increased disease activity in SLE and a higher risk of leucopenia and autoantibody-positive subphenotypes in pSS.

语种英语
所属项目编号2010CB529105 ; 2014CB541901 ; 2010DFB34000 ; 81120108020 ; 31270914 ; 81071940 ; NCET-12-0600 ; 7122196
资助者National Key Basic Research Program of China (973 program) ; Program of International Science &amp ; Technology Cooperation of MOST ; Major International Joint Research Project of NSFC ; National Natural Science Foundation of China ; Education Ministry&prime ; s New Century Outstanding Talents Supporting Plan ; Beijing Natural Science Foundation ; National Key Basic Research Program of China (973 program) ; Program of International Science &amp ; Technology Cooperation of MOST ; Major International Joint Research Project of NSFC ; National Natural Science Foundation of China ; Education Ministry&prime ; s New Century Outstanding Talents Supporting Plan ; Beijing Natural Science Foundation
WOS记录号WOS:000363348800018
引用统计
被引频次:8[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/58029
专题北京大学第二临床医学院
作者单位1.Peking Univ, Dept Rheumatol & Immunol, Peoples Hosp, Beijing 100044, Peoples R China
2.Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Rheumatol & Immunol, Urumqi, Peoples R China
3.Anhui Med Univ, Inst Dermatol, Hosp 1, Dept Dermatol, Hefei, Peoples R China
推荐引用方式
GB/T 7714
Du, Yan,Su, Yin,He, Jing,et al. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjogren′s syndrome[J]. ANNALS OF THE RHEUMATIC DISEASES,2015,74(11):2070-2075.
APA Du, Yan.,Su, Yin.,He, Jing.,Yang, Yue.,Shi, Yamei.,...&Li, Zhanguo.(2015).Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjogren′s syndrome.ANNALS OF THE RHEUMATIC DISEASES,74(11),2070-2075.
MLA Du, Yan,et al."Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjogren′s syndrome".ANNALS OF THE RHEUMATIC DISEASES 74.11(2015):2070-2075.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Du, Yan]的文章
[Su, Yin]的文章
[He, Jing]的文章
百度学术
百度学术中相似的文章
[Du, Yan]的文章
[Su, Yin]的文章
[He, Jing]的文章
必应学术
必应学术中相似的文章
[Du, Yan]的文章
[Su, Yin]的文章
[He, Jing]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。